Literature DB >> 2758775

Anticardiolipin antibodies in Behçet's syndrome: a predictor of a more severe disease.

R M Pereira1, C R Gonçalves, C Bueno, E de S Meirelles, W Cossermelli, R M de Oliveira.   

Abstract

A high incidence of anticardiolipin antibodies were detected in 7 of 20 patients (35%) with Behçet's Syndrome. Three patients had IgG-ab, three had IgM-ab and one had both IgG and IgM antibodies. IgG-ACA was detected mainly in patients with ocular disease (30%) and one of them also has cerebral vascular disease. A lower incidence of ACA was found in the patients taking steroids compared with the ones taking other drugs. This work draws attention to the more severe disease present in patients with ACA and also the possibility of such tests become negative in patients taking immunosuppressive drugs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2758775     DOI: 10.1007/BF02030089

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  9 in total

1.  [Anticardiolipin antibodies in Behçet's disease].

Authors:  M Hamza; O Meyer
Journal:  Presse Med       Date:  1986 Jul 5-12       Impact factor: 1.228

Review 2.  Anti-phospholipid antibodies.

Authors:  E N Harris; A E Gharavi; G R Hughes
Journal:  Clin Rheum Dis       Date:  1985-12

3.  Anticardiolipin antibodies: occurrence in Behçet's syndrome.

Authors:  R G Hull; E N Harris; A E Gharavi; A Tincani; R A Asherson; G Valesini; A M Denman; G Froude; G R Hughes
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103

4.  Negative anticardiolipin antibodies and vascular complications in Behçet's syndrome.

Authors:  J Efthimiou; E N Harris; G R Hughes
Journal:  Ann Rheum Dis       Date:  1985-10       Impact factor: 19.103

5.  Behcet's syndrome in 32 patients in Yorkshire.

Authors:  M A Chamberlain
Journal:  Ann Rheum Dis       Date:  1977-12       Impact factor: 19.103

6.  Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.

Authors:  M L Boey; C B Colaco; A E Gharavi; K B Elkon; S Loizou; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08

7.  Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus.

Authors:  E N Harris; A E Gharavi; M L Boey; B M Patel; C G Mackworth-Young; S Loizou; G R Hughes
Journal:  Lancet       Date:  1983-11-26       Impact factor: 79.321

8.  Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus.

Authors:  M D Lockshin; M L Druzin; S Goei; T Qamar; M S Magid; L Jovanovic; M Ferenc
Journal:  N Engl J Med       Date:  1985-07-18       Impact factor: 91.245

9.  Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis.

Authors:  R T Canoso; R M de Oliveira
Journal:  Am J Hematol       Date:  1988-04       Impact factor: 10.047

  9 in total
  4 in total

Review 1.  Anticardiolipin (aCL) antibodies in a patient with Behçet's syndrome with vena cava inferior thrombosis.

Authors:  D G Ebo; P G Bracke; L S De Clerck; L M Francx; W J Stevens
Journal:  Clin Rheumatol       Date:  1997-01       Impact factor: 2.980

2.  Absence of antiphospholipid antibodies in Behçet's disease.

Authors:  M Karmochkine; M C Boffa; B Wechsler; J C Piette; P Godeau
Journal:  Ann Rheum Dis       Date:  1993-08       Impact factor: 19.103

3.  Auto-immunity profile evaluation during different clinical manifestations of Behçet disease in Algerian patients: effect of corticosteroid treatment.

Authors:  Fatmazohra Djaballah-Ider; Abdelhamid Djaballah; Zineb Djeraba; Samia Chaib; Chafia Touil-Boukoffa
Journal:  Inflammopharmacology       Date:  2019-02-05       Impact factor: 4.473

4.  Behçet's Disease as a Model of Venous Thrombosis.

Authors:  Micaela La Regina; Armen Yuri Gasparyan; Francesco Orlandini; Domenico Prisco
Journal:  Open Cardiovasc Med J       Date:  2010-02-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.